- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Revelation Partners
BioCentury | Nov 15, 2023
Finance
Nov. 14 Quick Takes: TPG leads $85M B round for ADC play MBrace
Plus: Nouscom raises €67.5M series C and more from Eyebio, Glox, Bayer and Ketabon
BioCentury | Apr 25, 2023
Deals
April 25 Quick Takes: Final outcome for decades-old Spectrum is Assertio merger
Plus: Arrowhead buoyed by pulmonary data and updates from Novartis, Vedanta and Ventoux
BioCentury | Jun 15, 2022
Market Access
June 14 Quick Takes: ICER weighs in on Amylyx’s ALS treatment
Plus EQRx’s first regulatory submission, WHO to discuss monkeypox status and updates from PureTech, Tilt and more
BioCentury | May 9, 2022
Finance
VCs back Aspen with $147.5M as neuron replacement therapy heads toward clinic
Tapping GV, Lyfe and Revelation as series B leaders, biotech sought deep-pocketed syndicate with long-term view to match series A backer
BioCentury | Feb 8, 2022
Finance
Feb. 7 Quick Takes: WuXi Biologics shares fall after landing on Commerce list
Plus mega-rounds for Endeavor, Dewpoint and updates from Koneksa, ObsEva and more
BioCentury | Dec 2, 2021
Finance
Dec. 1 Quick Takes: New round pushes Abogen’s venture haul over $1B
Plus Hotspot, Apollo, Curie, ICER, Zogenix, Chinook, BeyondSpring
BioCentury | Oct 23, 2021
Product Development
Oct. 22 Quick Takes: FDA approves Genentech’s ocular implant for wet AMD
$118M IPO values Xilio at $427M, plus Genentech, Merck, Sanofi and more
BioCentury | Dec 21, 2020
Finance
Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more
SomaLogic tops off recent series AProteomics company SomaLogic Inc. added another $81 million to the crossover-heavy series A financing it disclosed in November, bringing the round’s total
BioCentury | Jun 29, 2015
Finance
Leerink's Revelation
Why Revelation, Leerink partnered to realign venture syndicates
Items per page:
1 - 10 of 10